KRIBIOLISA™ Anti-Adalimumab ELISA

Enzyme Immunoassay for the quantitative determination of Anti-Adalimumab antibodies in human serum and plasma.

Request Pricing
KRISHGEN BioSystems

Receive your quote directly from the manufacturer.

Ease of Use
After Sales Service
Value for Money
Write your own review

Anti-Adalimumab ELISA for screening of antibodies to Adalimumab in human serum and plasma.

Intended Use:

The KRIBIOLISA™ Anti-Adalimumab ELISA is used as an analytical tool for quantitative determination of Anti- Adalimumab in serum, plasma and cell culture supernatant.

Principle:

The method employs the quantitative sandwich enzyme immunoassay technique. A commercially available Adalimumab is pre-coated onto microwells. Samples and Standards are pipetted into microwells and antibodies to Adalimumab present in the sample are bound by the capture antibody. Then, a HRP (horseradish peroxidase) conjugated Adalimumab is pipette and incubated simultaneously with samples. After washing microwells in order to remove any non-specific binding, the ready to use substrate solution (TMB) is added to microwells and color develops proportionally to the amount of Anti-Adalimumab in the sample. Color development is then stopped by addition of stop solution. Absorbance is measured at 450 nm.

  • Calibrator Range: 0 ng/ml - 640 ng/ml
  • Sensitivity: 8 ng/ml
  • Sample Type: human serum and plasma
  • Reactivity: Human
  • Shipping Condition: 2 - 8 Deg C
  • Detection Method: Colorimetric
  • Usage: For In-Vitro Diagnostic Use Only
  • Research Area: Therapeutic Drug Monitoring

Product Overview

Links